Here are relevant reports on : inflammatory-bowel-disease-treatment-market
-
US Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Home Care Settings) - Forecast to 2031
The US Respiratory Care Devices market, valued at US$9.40 billion in 2025, stood at US$10.02 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$14.56 billion by the end of the period. This growth is primarily driven by an increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with an aging population that is more susceptible to breathing disorders.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Incontinence and Ostomy Care Market by Procedure (Ileostomy, Urostomy, Colostomy), Disease (Cancer, Crohn's Disease, Diarrhea), Product (Adsorbent, Deodorizer, Ostomy Bag, Skin Barrier), Application (Protection, Cleansing) Global Forecasts to 2019
The global incontinence and ostomy care market is estimated to grow at a high rate from 2014 to 2019. The key drivers propelling the growth of global incontinence and ostomy care market include global rise in population of obese and geriatric individuals, development of innovative and personalized products offering greater patient comfort, rising awareness and acceptance related to ostomy care products, and increasing prevalence of target diseases.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Foregut Surgery Devices Market by Product (Endoscope, Hand Instrument), Procedure (Complex Esophagogastric Surgery, Per-Oral Endoscopic Myotomy), Disease (Reflex Disease, Hiatal Hernias), End User (Hospitals) - Global Forecast to 2022
The global foregut surgery devices market is expected to reach USD 699.7 Million by 2023 from USD 485.1 Million in 2018, growing at a CAGR of 7.6% from 2018 to 2023. Rising incidence and prevalence of diseases, technological advancements, rising number of foregut surgical procedure some of the major driving factors driving the growth of the global foregut surgery devices market. However, the high cost of surgery hindering the growth of this market to a certain extent.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022
The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031
The Asia Pacific respiratory care devices market is projected to reach USD 8.76 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031
The europe respiratory care devices market, valued at USD 5.97 billion in 2025, stood at USD 6.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 8.96 billion by the end of the period. The key players in the Europe respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), and among other players.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030
The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031
The North America Respiratory Care Device market, valued at US$9.88 billion in 2025, stood at US$10.53 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$15.31 billion by the end of the period. The North America respiratory care devices market has been growing as the number of chronic respiratory diseases, such as COPD, asthma, and sleep apnea, continues to rise.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
- Published: February 2021
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
